| Andrew Schumacher, PA | |
|
6252 Mahoning Ave, Austintown, OH 44515-2003 | |
| (330) 792-7418 | |
| (330) 656-5901 |
| Full Name | Andrew Schumacher |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 18 Years |
| Location | 6252 Mahoning Ave, Austintown, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609953579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PENDING (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
The WHO and FDA approve drugs to treat malaria, tuberculosis and other diseases in low- and middle-income countries, but "some of the manufacturers, predominantly Chinese and Indian firms, may be knowingly producing" poor quality medicines, according to "the conclusion of my research teams' studies, published this week in the journal Research and Reports in Tropical Medicine," Roger Bate, resident scholar with the American Enterprise Institute and lead author of the studies, writes in a Washington Post opinion piece.
The number of deaths in children due to lower respiratory infections (LRIs) such as pneumonia and influenza has come down considerably. Yet, they still account for the highest number of deaths in children under 5 years of age, at one in seven of all deaths in this age group, according to a detailed study published in the journal The Lancet Infectious Diseases.
A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a £20million grant from the Wolfson Foundation, it was announced today.
Amylin Pharmaceuticals, Inc. today announced that new data from its obesity program will be presented at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society, to be held in Washington, D.C. October 24-28. Phase 2 data from the pramlintide/metreleptin combination treatment clinical program will be the subject of a late-breaking oral presentation.
Using a powerful data-crunching technique, Johns Hopkins researchers have sorted out how a protein keeps defective genetic material from gumming up the cellular works. The protein, Dom34, appears to "rescue" protein-making factories called ribosomes when they get stuck obeying defective genetic instructions, the researchers report in the Feb. 27 issue of Cell.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Schumacher, PA 5700 Darrow Rd, Suite 106, Hudson, OH 44236-5021 Ph: (330) 656-5911 | Andrew Schumacher, PA 6252 Mahoning Ave, Austintown, OH 44515-2003 Ph: (330) 792-7418 |
News Archive
The WHO and FDA approve drugs to treat malaria, tuberculosis and other diseases in low- and middle-income countries, but "some of the manufacturers, predominantly Chinese and Indian firms, may be knowingly producing" poor quality medicines, according to "the conclusion of my research teams' studies, published this week in the journal Research and Reports in Tropical Medicine," Roger Bate, resident scholar with the American Enterprise Institute and lead author of the studies, writes in a Washington Post opinion piece.
The number of deaths in children due to lower respiratory infections (LRIs) such as pneumonia and influenza has come down considerably. Yet, they still account for the highest number of deaths in children under 5 years of age, at one in seven of all deaths in this age group, according to a detailed study published in the journal The Lancet Infectious Diseases.
A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a £20million grant from the Wolfson Foundation, it was announced today.
Amylin Pharmaceuticals, Inc. today announced that new data from its obesity program will be presented at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society, to be held in Washington, D.C. October 24-28. Phase 2 data from the pramlintide/metreleptin combination treatment clinical program will be the subject of a late-breaking oral presentation.
Using a powerful data-crunching technique, Johns Hopkins researchers have sorted out how a protein keeps defective genetic material from gumming up the cellular works. The protein, Dom34, appears to "rescue" protein-making factories called ribosomes when they get stuck obeying defective genetic instructions, the researchers report in the Feb. 27 issue of Cell.
› Verified 7 days ago
Ms. Jennifer Rhea Lash, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4990 Mahoning Ave, Austintown, OH 44515 Phone: 330-992-4100 | |
Stephanie Kristen Lusk, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5760 Patriot Blvd, Austintown, OH 44515 Phone: 330-270-8610 | |
Carli Held, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 5760 Patriot Blvd, Austintown, OH 44515 Phone: 330-953-0243 |